Trial intelligence / Profile preview

Cozaar for renal dysfunction prevention after liver transplant

NCT00275639Phase 4Completed

Sponsor
Mayo Clinic
Start
Dec 2004
Primary completion
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of losartan in chronic kidney disease (CKD), sponsored by Mayo Clinic. Primary endpoint: Development of renal dysfunction at 1 year. Started Dec 2004; status: completed.

02

Drugs

losartan
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT00275639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00275639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call